2015
DOI: 10.1002/ajh.24202
|View full text |Cite
|
Sign up to set email alerts
|

Transferrin receptor 2 mutations in patients with juvenile hemochromatosis phenotype

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
6
0

Year Published

2019
2019
2024
2024

Publication Types

Select...
7
2

Relationship

2
7

Authors

Journals

citations
Cited by 9 publications
(6 citation statements)
references
References 8 publications
0
6
0
Order By: Relevance
“…Cardiomyopathy most frequently occurs in the severe forms of iron overload (68,86). However, patients with adult hemochromatosis have an increased risk of cardiomyopathy compared to healthy controls (87).…”
Section: Cardiac Damagementioning
confidence: 99%
See 1 more Smart Citation
“…Cardiomyopathy most frequently occurs in the severe forms of iron overload (68,86). However, patients with adult hemochromatosis have an increased risk of cardiomyopathy compared to healthy controls (87).…”
Section: Cardiac Damagementioning
confidence: 99%
“…It is caused by mutations of TFR2, whose allele prevalence was estimated between 0.0001 and 0.0004 (128). shown that severe mutations could lead to juvenile-like hemochromatosis and increased iron indices in childhood (86,134,135). Mutations are most often private [reported in HGMD ( 130)] although the 1780-1791del (AVAQ 594-597) was found in a few patients worldwide (136,137), and a cluster of the p.Tyr250* mutation was found in Sicily (134,138).…”
Section: Hemochromatosis Type-3 (Omim #604250)mentioning
confidence: 99%
“…For the second family the genotype-phenotype correlation was more complex, the c.998C>T p.(Pro333Leu) variant of TFR2 is at for binding to saturated transferrin. 5,6 This interaction was further demonstrated by functional studies by Ravasi et al 7 The variant was previously described only in homozygosis, in two subjects from two different case series affected by type 3 HH with autosomal recessive inheritance. 5,7 The genotype identified in the proband, does not permit to…”
mentioning
confidence: 70%
“…Current recommendations suggest a stepwise approach (single-gene testing) in which sequencing should be made initially according to clinical features (i.e., prioritizing HJV and HAMP in patients with early-onset and severe iron overload) [8]. While this is reasonable, it is time consuming and does not take appropriately into account the emerging phenotype overlaps between different forms of HH [20][21][22][23], the possible occurrence of digenic inheritance or the presence of rare and severe HFE mutations, and the variable phenotype of ferroportin mutation [1]. Previous studies demonstrated the feasibility, sensitivity and cost-effectiveness of NGS-targeted gene panels and exome sequencing in patients suspected for non-HFE hemochromatosis and Ferroportin disease [24][25][26][27].…”
Section: Discussionmentioning
confidence: 99%